A small Wall Street firm has landed a big payday thanks to a $US4.5 billion deal between a multi-billion dollar private equity firm and a pharmaceutical firm.
Parexel, a pharmaceutical research firm, announced on Tuesday that it would be acquired by Pamplona Capital Management, a private equity and advisory firm with $US10 billion under management. Pamplona agreed to pay about $US88 per share in cash for Parexel.
Perella Weinberg Partners worked as Pamplona’s adviser on the deal. The financial advisory firm, which was founded in 2006, maintains offices in nine cities including New York and London, and has 600 employees.
The firm is set to make around $US10 million to $US15 million for its role in the deal, according to data from Freeman & Co.
Goldman Sachs, Parexel’s adviser, should receive about $US25 million to $US30 million.